» Articles » PMID: 15239631

One Liver, Three Recipients: Segment IV from Split-liver Procedures As a Source of Hepatocytes for Cell Transplantation

Overview
Journal Transplantation
Specialty General Surgery
Date 2004 Jul 9
PMID 15239631
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14 x 10(8) cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.

Citing Articles

Human Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective.

Nulty J, Anand H, Dhawan A Stem Cells Transl Med. 2023; 13(3):204-218.

PMID: 38103170 PMC: 10940836. DOI: 10.1093/stcltm/szad084.


Hepatocyte Transplantation to the Liver via the Splenic Artery in a Juvenile Large Animal Model.

Siefert J, Hillebrandt K, Moosburner S, Podrabsky P, Geisel D, Denecke T Cell Transplant. 2019; 28(1_suppl):14S-24S.

PMID: 31842585 PMC: 7016464. DOI: 10.1177/0963689719885091.


Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study.

Spada M, Porta F, Righi D, Gazzera C, Tandoi F, Ferrero I Stem Cell Rev Rep. 2019; 16(1):186-197.

PMID: 31792768 PMC: 6987134. DOI: 10.1007/s12015-019-09925-z.


Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator.

Lee C, Dhawan A, Iansante V, Filippi C, Mitry R, Tang J J Mol Med (Berl). 2019; 97(4):563-577.

PMID: 30820592 PMC: 6440943. DOI: 10.1007/s00109-019-01747-3.


Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure.

da Fonseca Cardoso L, Moreira L, Pinto M, Henriques-Pons A, Alves L Can J Gastroenterol Hepatol. 2018; 2018:2593745.

PMID: 30065914 PMC: 6051327. DOI: 10.1155/2018/2593745.